Douglas McCorkle - Regeneron Pharmaceuticals Vice President Controller, Assistant Treasurer

REGN -- USA Stock  

USD 286.15  9.72  3.29%

  President
Mr. Douglas S. McCorkle CPA. has resigned as Vice President Controller and Assistant Treasurer of Regeneron Pharmaceuticals Inc. Prior to that date he served as Controller and Assistant Treasurer since 1998. Prior to joining the Company Mr. McCorkle was Controller of Intergen Company a manufacturer of biopharmaceutical products a position he held since 1997. From 1990 to 1996 Mr. McCorkle was employed with Coopers Lybrand L.L.P. where he specialized in biotechnology clients and served in various positions including Audit Manager from 1995 to 1996. Mr. McCorkle is a Certified Public Accountant in the State of New York.
Age: 58  President Since 2007      
914-847-7000  http://www.regeneron.com

Douglas McCorkle Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 11.57 % which means that it generated profit of $11.57 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 24.43 % meaning that it created $24.43 on every $100 dollars invested by stockholders.
The company currently holds 711.3M in liabilities with Debt to Equity (D/E) ratio of 7.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Regeneron Pharmaceuticals has Current Ratio of 3.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Douglas BoothePerrigo Company plc
2013
Michael PariniVertex Pharmaceuticals Incorpor
2017
Jatin ShahPerrigo Company plc
2005
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Raghav ChariDr Reddys Laboratories Ltd
2013
K RaoDr Reddys Laboratories Ltd
2016
Catherine KnuppZoetis
2012
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Umang VohraDr Reddys Laboratories Ltd
2013
Kimberly WhiteVertex Pharmaceuticals Incorpor
2018
Alejandro BernalZoetis
2015
Stefan WeiskopfZoetis
2013
James DillardPerrigo Company plc
2019
Scott JamisonPerrigo Company plc
2011
Ian SmithVertex Pharmaceuticals Incorpor
2017
Roman TrawickiZoetis
2015
Marc CouckePerrigo Company plc
N/A
Louis YuPerrigo Company plc
2013
Amit SachdevVertex Pharmaceuticals Incorpor
2017
John WesolowskiPerrigo Company plc
2016

Entity Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York. Regeneron Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 7549 people.Regeneron Pharmaceuticals (REGN) is traded on BATS Exchange in USA and employs 7,549 people.

Regeneron Pharmaceuticals Leadership Team

Charles Baker, Independent Director
Joseph Goldstein, Independent Director
Anthony Coles, Independent Director
George Sing, Independent Director
Peter Powchik, Senior Vice President - Clinical Development
Jay Markowitz, Senior Vice President - Portfolio Management
Robert Terifay, Sr. VP of Commercial
Robert Landry, CFO and Sr. VP of Fin.
Michael Brown, Independent Director
Christine Poon, Independent Director
Neil Stahl, Executive VP of RandD
Marion McCourt, Senior Vice President and Head of Commercial
George Yancopoulos, Chief Scientific Officer and President - Regeneron Laboratories, Director
Huda Zoghbi, Director
Bonnie Bassler, Director
Joseph LaRosa, Senior Vice President General Counsel, Secretary
Daniel Plew, Senior Vice President General Manager - Industrial Operations and Product Supply
Leonard Schleifer, President CEO, Director
Alfred Gilman, Independent Director
Roy Vagelos, Chairman of the Board
Michael Aberman, Vice President - Strategy
Manisha Narasimhan, IR Contact
Douglas McCorkle, Vice President Controller, Assistant Treasurer
Marc TessierLavigne, Independent Director
Christopher Fenimore, Vice President Controller
Arthur Ryan, Independent Director

Stock Performance Indicators

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Currently Active Assets on Macroaxis

GOOG   
Purchased one share of
few hours ago
Traded for 1221.15
UGAZ   
Purchased over 100 shares of
few hours ago
Traded for 19.55
TWTR   
Purchased over 40 shares of
few hours ago
Traded for 43.23
JD   
Purchased over 60 shares of
few hours ago
Traded for 30.83
MDT   
Purchased few shares of
few hours ago
Traded for 111.18
Additionally take a look at Your Equity Center. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Search macroaxis.com